---
figid: PMC5815314__nihms851541f2
figlink: /pmc/articles/PMC5815314/figure/F2/
number: F2
caption: PD-1 and its downstream effect. Upon binding to ligands, PD-1’s ITIMs and
  ITSMs are phosphorylated by Src-family tyrosine kinases. The phosphorylated tyrosine
  residue subsequently recruits SHP-2 and SHP-1/SHP-2 in ITIM and ITSM, respectively.
  Activated PD-1 eventually hinders PI3K/Akt and RAS/MEK/ERK pathways, thwarts the
  function of PKC-θ and ZAP70 phosphorylation and inhibits glycolysis. The net effect
  is decreased cell cycle progression, IL-2 production, T-cell activation and effector
  T-cell development and increased apoptosis.Src, Src-family tyrosine kinases; ITIM,
  immunoreceptor tyrosine-based inhibitory motif; ITSM, immunoreceptor tyrosine-based
  switch motif; P in red circle, phosphorylated tyrosine residues; SHP1 and SHP2,
  Src homology 2 domain-containing phosphatases, PI3K/Akt, Phosphatidylinositol-4,5-bisphosphate
  3-kinase; Akt, Protein kinase B; PKC-θ, protein kinase C-theta; RAS/MEK/ERK, RAS/MEK/ERK
  pathway.
pmcid: PMC5815314
papertitle: Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms.
reftext: Chi Young Ok, et al. Cancer Treat Rev. ;54:99-109.
pmc_ranked_result_index: '78536'
pathway_score: 0.9127333
filename: nihms851541f2.jpg
figtitle: PD-1 and its downstream effect
year: ''
organisms:
- Mus musculus
- Human gammaherpesvirus 4
- Coxsackievirus A21
- Human immunodeficiency virus
- Homo sapiens
- Oryctolagus cuniculus
ndex: ebcd5fbb-df0f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5815314__nihms851541f2.html
  '@type': Dataset
  description: PD-1 and its downstream effect. Upon binding to ligands, PD-1’s ITIMs
    and ITSMs are phosphorylated by Src-family tyrosine kinases. The phosphorylated
    tyrosine residue subsequently recruits SHP-2 and SHP-1/SHP-2 in ITIM and ITSM,
    respectively. Activated PD-1 eventually hinders PI3K/Akt and RAS/MEK/ERK pathways,
    thwarts the function of PKC-θ and ZAP70 phosphorylation and inhibits glycolysis.
    The net effect is decreased cell cycle progression, IL-2 production, T-cell activation
    and effector T-cell development and increased apoptosis.Src, Src-family tyrosine
    kinases; ITIM, immunoreceptor tyrosine-based inhibitory motif; ITSM, immunoreceptor
    tyrosine-based switch motif; P in red circle, phosphorylated tyrosine residues;
    SHP1 and SHP2, Src homology 2 domain-containing phosphatases, PI3K/Akt, Phosphatidylinositol-4,5-bisphosphate
    3-kinase; Akt, Protein kinase B; PKC-θ, protein kinase C-theta; RAS/MEK/ERK, RAS/MEK/ERK
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ZAP70
  - PIK3R4
  - PIK3CA
  - AKT2
  - AKT1
  - AKT3
  - SRC
  - PIK3CB
  - PIK3R5
  - PTPN11
  - PIK3CG
  - HRAS
  - PIK3R6
  - PIK3CD
  - PDCD1
  - MAP2K1
  - PIK3R3
  - IL2
  - MAP2K2
  - MAPK3
  - MAPK1
  - PTPN6
  - NRAS
  - KRAS
  - Cancer
genes:
- word: ZAP70
  symbol: ZAP70
  source: hgnc_symbol
  hgnc_symbol: ZAP70
  entrez: '7535'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: RAS/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: IL-2
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: RAS/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SHP-1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS/MEK/ERK
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5815314__F2
redirect_from: /figures/PMC5815314__F2
figtype: Figure
---
